About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hematology
›
top-articles
Department of Hematology
33
(top 2%)
papers
837
(top 2%)
citations
15
(top 2%)
h
-index
28
(top 2%)
g
-index
37
all documents
871
doc citations
366
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Clinical application of the PFA-100®
Current Opinion in Hematology
2002
165
2
Contemporary platelet function testing
Clinical Chemistry and Laboratory Medicine
2010
84
3
The LOC387715 Polymorphism, Inflammatory Markers, Smoking, and Age-Related Macular Degeneration
Ophthalmology
2008
59
4
Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice
Experimental Hematology
2013
52
5
Circulating Inflammatory Markers and Hemostatic Factors in Age-Related Maculopathy: A Population-Based Case–Control Study
Experimental Hematology
2007
48
6
Laboratory assays for von Willebrand Factor: relative contribution to the diagnosis of von Willebrand’s disease
Pathology
1997
45
7
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials
Leukemia
2006
42
8
Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis
Bone Marrow Transplantation
2016
39
9
Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach
Pathology
1999
36
10
Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?
Clinical Chemistry and Laboratory Medicine
2010
33
11
Pharmacogenetics of vitamin K antagonists: useful or hype?
Clinical Chemistry and Laboratory Medicine
2009
31
12
The Journal Impact Factor: don't expect its demise any time soon
Clinical Chemistry and Laboratory Medicine
2009
29
13
Laboratory testing in pharmacies
Clinical Chemistry and Laboratory Medicine
2010
27
14
Evaluation of point-of-care testing in critically unwell patients: comparison with clinical laboratory analysers and applicability to patients with Ebolavirus infection
Pathology
2015
18
15
The MDA-180 coagulation analyser: a laboratory evaluation
Pathology
1997
16
16
Template bleeding time and PFA-100R have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients - a rebuttal
Journal of Thrombosis and Haemostasis
2004
16
17
Laboratory medicine and natural disasters: are we ready for the challenge?
Clinical Chemistry and Laboratory Medicine
2010
16
18
Rapid diagnosis of hemochromatosis gene Cys282Tyr mutation by SSCP analysis
Clinical Chemistry and Laboratory Medicine
1998
14
19
Gender related issues in thrombosis and hemostasis
Expert Review of Hematology
2017
14
20
Upfront Imatinib Therapy in CML Patients with Rapid Switching to Nilotinib for Failure to Achieve Molecular Targets or Intolerance Achieves High Overall Rates of Molecular Response and a Low Risk of Progression - An Update of the TIDEL-II Trial
Blood
2011
14
21
Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing
American Journal of Clinical Pathology
2004
13
22
The missing link between genotype, phenotype and clinics
Biochemia Medica
0
12
23
Sweet's syndrome in hairy cell leukemia
Journal of the American Academy of Dermatology
1989
11
24
Donor T cells for CAR T cell therapy
Biomarker Research
2022
9
25
Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
ImmunoTargets and Therapy
2021
7
26
Selective Escalation of Imatinib Therapy and Early Switching to Nilotinib In De Novo Chronic Phase CML Patients: Interim Results From the TIDEL-II Trial
Blood
2010
7
27
Aminopeptidase-N (CD13; gp 150): Contrasting patterns of enzymatic activity in blood from patients with myeloid or lymphoid leukemia
Leukemia Research
1995
5
28
The indirect estimation of hemoglobin concentration in whole blood
Pathology
1991
2
29
Maintaining Imatinib ≥600 Mg Daily in the First 12 Months of Chronic Phase CML Treatment Is Associated with Superior Event-Free Survival at 5 Years.
Blood
2009
2
30
The Wnt/β-Catenin Pathway Promotes Growth and Survival of Acute Lymphoblastic Leukaemia (ALL) Cells In Vitro.
Blood
2005
1
31
Monocytes Are Associated with Impaired T-Cell Immunity and Residual Interim-PET/CT Avidity After 4 Cycles of CHOP-R In Patients with High-Risk DLBCL,
Blood
2011
1
32
Bortezomib-Based Induction Overcomes Effect of 1q Amplification On Response in Newly-Diagnosed Myeloma and Results in Similar 2 Year Event-Free Survival
Blood
2012
1
33
Laboratory Evaluation of von Willebrand Disease: Phenotypic Analysis
Blood
2009
0
34
Unique case involving chromosomes 3 and 11 in myelodysplastic syndromes (MDS) confirmed by microarray studies
Pathology
2017
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.